Bharat Immunolog

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE994B01014
  • NSEID:
  • BSEID: 524663
INR
17.30
-0.03 (-0.17%)
BSENSE

May 06

BSE+NSE Vol: 23.0 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 936506,
    "name": "Bharat Immunolog",
    "stock_name": "Bharat Immunolog",
    "full_name": "Bharat Immunological & Biological Corporation Ltd",
    "name_url": "stocks-analysis/bharat-immunolog",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "17.30",
    "chg": -0.03,
    "chgp": "-0.17%",
    "dir": -1,
    "prev_price": "17.33",
    "mcapval": "75.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524663,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE994B01014",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "23.0 k",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bharat-immunolog-936506-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3973191",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BharatImmunolog_mojoScore_3973191.png",
        "date": "2026-05-04 10:10:17",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 Apr 2024. However, the analysis and financial metrics discussed here reflect the company’s current position as of 04 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3955841",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatImmunolog_mojoScore_3955841.png",
        "date": "2026-04-21 10:10:18",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 Apr 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here represent the company’s current position as of 21 April 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical standing."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3941477",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/BharatImmunolog_mojoScore_3941477.png",
        "date": "2026-04-10 10:10:44",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 09 Apr 2024. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 14.62 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs1462-3924613",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_priceRelatedfactors_3924613.png",
        "date": "2026-03-30 11:59:50",
        "description": "For the second consecutive session, Bharat Immunological & Biological Corporation Ltd has extended its decline, hitting a fresh 52-week low of Rs 14.62 on 30 Mar 2026. This latest drop comes amid a broader sector underperformance and persistent concerns over the company’s financial health."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3923796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_mojoScore_3923796.png",
        "date": "2026-03-30 10:10:17",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 09 April 2024. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 March 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 15.55 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-hits-52-week-low-amidst-continued-downtrend-3919806",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_priceRelatedfactors_3919806.png",
        "date": "2026-03-27 13:49:19",
        "description": "A sharp decline of 4.29% today dragged Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 15.55, extending its downward trajectory despite a brief two-day rally. This fall comes amid a broader market weakness, but the stock’s underperformance is notably more severe than its sector peers."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd Falls to 52-Week Low of Rs 15.66 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bharat-immunological-biological-corporation-ltd-falls-to-52-week-low-of-rs1566-3907846",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_priceRelatedfactors_3907846.png",
        "date": "2026-03-23 12:36:33",
        "description": "A sharp decline has pushed Bharat Immunological & Biological Corporation Ltd to a fresh 52-week low of Rs 15.66 on 23 Mar 2026, marking a significant 45.6% drop from its 52-week high of Rs 28.80. This fall comes amid a broader market downturn but is notably more severe than sector and benchmark indices, reflecting company-specific pressures."
      },
      {
        "title": "Bharat Immunological & Biological Corporation Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/bharat-immunological-biological-corporation-ltd-is-rated-strong-sell-3893261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/BharatImmunolog_mojoScore_3893261.png",
        "date": "2026-03-16 10:10:15",
        "description": "Bharat Immunological & Biological Corporation Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 09 April 2024, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed here are based on the company’s current position as of 16 March 2026, providing investors with an up-to-date view of its performance and prospects."
      },
      {
        "title": "Why is Bharat Immunological & Biological Corporation Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-bharat-immunological-biological-corporation-ltd-fallingrising-3877606",
        "imagepath": "",
        "date": "2026-03-07 01:02:44",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>On 06-Mar, the stock closed at ₹16.89, registering a marginal decline of 0.3% or ₹0.05. This drop, while modest on the day, is consistent with a broader trend of negative returns over multiple time horizons. Over the past week, the share price has fallen by 6.17%, more than double the Sensex’s decline of 2.91%. The one-month performance is even more pronounced, with a 16.18% decrease compared to the Sensex’s 5.58% fall. Year-to-date, the stock has lost 15.84%, significantly underperforming the benchmark’s 7.39% decline.</p>\n<p>Looking further back, the stock’s underperformance is stark. Over the last year, Bharat Immunological &amp; Biological Corporation Ltd’s shares have dropped nearly 25%, while the Sensex has gained 6.16%. The thre..."
      }
    ],
    "total": 97,
    "sid": "936506",
    "stock_news_url": "https://www.marketsmojo.com/news/bharat-immunological-biological-corporation-936506"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "07-Aug-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.",
      "datetime": "29-Feb-2024",
      "details": "BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.",
      "source": "BSE"
    },
    {
      "caption": "Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.",
      "datetime": "13-Dec-2023",
      "details": "Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 16.08.2024 Under Regulation 29 Of SEBIS LODR.

07-Aug-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/08/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 16th August 2024 for General Purpose.

Board Meeting Intimation for Intimation Of Date Of Board Meeting On 08.03.2024 Under Regulation 29 Of SEBIS LODR.

29-Feb-2024 | Source : BSE

BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/03/2024 inter alia to consider and approve Pursuant to the Regulation 29 and other applicable Regulation(s) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is informed that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 08th March 2024 for General Purpose.

Compliance Of Regulation 34 Of LODR 2015 And Submission Annual Report For 34Th Annual General Meeting Scheduled On 29.12.2023.

13-Dec-2023 | Source : BSE

Submission of Draft Annual Report 2022-23 for AGM on 29.12.2023

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available